Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,155 | -5,485 | -1,990 | -48,169 | -324 |
| Depreciation Amortization | 245 | 156 | 74 | 46,357 | 183 |
| Accounts receivable | 63 | 52 | N/A | -644 | -768 |
| Other Working Capital | 100 | 732 | -362 | 287 | -178 |
| Other Operating Activity | 298 | 157 | 90 | 606 | 754 |
| Operating Cash Flow | $-7,449 | $-4,388 | $-2,188 | $-1,563 | $-333 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -239 | -220 | -93 | -145 | -144 |
| Investing Cash Flow | $-239 | $-220 | $-93 | $-145 | $-144 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32,161 | 16,606 | 16,606 | 6,638 | 3,928 |
| Other Financing Activity | -110 | -101 | -57 | -214 | -159 |
| Financing Cash Flow | $32,051 | $16,505 | $16,549 | $6,424 | $3,769 |
| Beginning Cash Position | 7,468 | 7,468 | 7,468 | 2,752 | 2,752 |
| End Cash Position | 31,831 | 19,365 | 21,736 | 7,468 | 6,044 |
| Net Cash Flow | $24,363 | $11,897 | $14,268 | $4,716 | $3,292 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,449 | -4,388 | -2,188 | -1,563 | -333 |
| Capital Expenditure | -239 | -220 | -93 | -145 | -144 |
| Free Cash Flow | -7,688 | -4,608 | -2,281 | -1,708 | -477 |